HEALTHCARE biomaterials maker Collagen Solutions is predicted to be bringing in £4.7 million in revenue by 2017.
That figure comes from broker Zeus Capital, which has just started covering the AIM-listed company.
Collagen Solutions manufactures collagen for use in a wide range of medical and diagnostic procedures.
Its genesis includes the Collbio, which has its manufacturing at the Nova Technology Park in Glasgow, buying some of the assets of failed Scottish life-sciences firm Angel Biotechnology in March last year.
That then went through a reverse takeover with the AIM-listed investment company Healthcare Investment Opportunities in December.
At the same time Collbio purchased Collagen Solutions, which was based in California, and decided to adopt that name for its stock-market listing.
Last month it recorded an annual operating loss of £480,000 but management said they were confident the business could eventually generate revenue of around £100 million by 2020.
In an extensive research note published yesterday Zeus pencilled in revenue of £1.1 million for 2015, £2.45 million in 2016 and £4.7 million across 2017.
The research suggests Collagen Solutions would make its maiden pre-tax profit in 2016 with a sum of £50,000, rising to more than £1.5 million the following year.
The note said: "We anticipate strong sales growth year-on-year which will be driven by a growing recognition of the high quality of its products and of the innovative development of new collagen-based biomaterials. We also believe that sales of approved products in the USA will gather momentum across the customer base."
Alongside that Zeus stated its belief that Collagen Solutions is undervalued in comparison to listed peers in the medical technology and biotechnology sectors.
Collbio was set up by Stewart White, who had previously been acting chief executive at Angel Biotechnology. The Collagen Solutions chairman David Evans holds the same role at fellow Scottish health industry company Omega Diagnostics.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereComments are closed on this article